Nevada Clinical Trials
Browse actively recruiting clinical trials with research sites in Nevada. Corterve gathers current studies from the public ClinicalTrials.gov registry so you can explore them by city and condition. Participation is voluntary; this page is general information and not medical advice.
Recruiting studies in Nevada
- Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)NCT05633654PHASE3Gilead SciencesTriple Negative Breast CancerLas Vegas, NV
- A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental VitiligoNCT07431177PHASE2Novartis PharmaceuticalsNon-segmental VitiligoLas Vegas, NV
- Study to Determine if BHV-1300 is Effective and Safe in Adults With Graves' DiseaseNCT07661056PHASE3Biohaven Therapeutics Ltd.Graves DiseaseLas Vegas, NV
- A Clinical Study of Molnupiravir to Prevent Severe Illness From Coronavirus Disease 2019 (COVID-19) in People Who Are High Risk (MK-4482-023)NCT06667700PHASE3Merck Sharp & Dohme LLCCoronavirus Disease (COVID-19)Carson City, NV
- A Study of Nemtabrutinib Plus Venetoclax vs Venetoclax + Rituximab (VR) in Second-line (2L) + Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) (MK-1026-010/BELLWAVE-010).NCT05947851PHASE3Merck Sharp & Dohme LLCLeukemia, Lymphocytic, Chronic, B-CellReno, NV
- Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)NCT06393374PHASE3Merck Sharp & Dohme LLCTriple-Negative Breast CancerLas Vegas, NV
- A Study With Tovorafenib (DAY101) as a Treatment Option for Progressive, Relapsed, or Refractory Langerhans Cell HistiocytosisNCT05828069PHASE2National Cancer Institute (NCI)Recurrent Langerhans Cell HistiocytosisLas Vegas, NV
- Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related ComorbiditiesNCT07752979PHASE2AbbVieObesityLas Vegas, NV
- Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal CancerNCT07392892PHASE2, PHASE3PfizerUntreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal AdenocarcinomaReno, NV
- Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative ColitisNCT07697456PHASE2AbbVieCrohn's DiseaseLas Vegas, NV
- A Master Protocol to Investigate Efficacy and Safety of Elecoglipron in Participants With Obesity or Overweight With or Without T2DMNCT07667803PHASE3AstraZenecaWeight ManagementReno, NV
- ALTO-100 in Bipolar Disorder With Depression (BD-D)NCT06656416PHASE2Alto NeuroscienceBipolar Disorder I or II With a Major Depressive EpisodeLas Vegas, NV
Clinical trials by Nevada metro
Popular conditions in Nevada
Frequently asked questions
- How do I find clinical trials in Nevada?
- Corterve aggregates actively recruiting clinical trials with sites in Nevada from the public ClinicalTrials.gov registry. Browse the studies on this page or take an assessment to find trials you may qualify for.
- Are clinical trials in Nevada free to join?
- Costs, travel support, and any payment for taking part vary by study. Ask the study team what is covered before you decide to join.
- What kinds of clinical trials are available in Nevada?
- Nevada research sites run studies across many areas including oncology, neurology, cardiology, and metabolic health. This page is general information and not medical advice; confirm any specific trial with your healthcare provider.